New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 29, 2022 - The FDA approved Mylan’s Ermeza (levothyroxine) oral solution.
Download PDF
Return to publications
